2023
Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report
Miller C, Taylor-Salmon E, Emuren L, Landry M, Gershon A, Miller G. Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report. BMC Infectious Diseases 2023, 23: 854. PMID: 38057696, PMCID: PMC10698951, DOI: 10.1186/s12879-023-08809-5.Peer-Reviewed Original ResearchConceptsVaricella-zoster virusVZV reactivationVaccine-strain varicella-zoster virusSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Latent varicella zoster virusSymptomatic COVID-19 infectionRespiratory syndrome coronavirus 2SARS-CoV2 infectionSyndrome coronavirus 2COVID-19 infectionVaccine-type strainsSARS-CoV-2Vesicular rashPediatric patientsSignificant morbidityClinical syndromeCoronavirus 2Single doseCase reportGeneral populationMechanical traumaDisease processHZ casesPhysiologic stress
2000
Viral strain identification in varicella vaccinees with disseminated rashes
LARUSSA P, STEINBERG S, SHAPIRO E, VAZQUEZ M, GERSHON A. Viral strain identification in varicella vaccinees with disseminated rashes. The Pediatric Infectious Disease Journal 2000, 19: 1037-1039. PMID: 11099082, DOI: 10.1097/00006454-200011000-00002.Peer-Reviewed Original ResearchConceptsVaricella-zoster virusBreakthrough varicellaVaccine strainVaricella vaccineVaccine-strain varicella-zoster virusWild-type VZV infectionLive attenuated varicella vaccineAttenuated varicella vaccineRecipients of vaccineOka vaccine strainDisseminated rashNatural varicellaVesicular rashPostvaccination periodVZV infectionClinical pictureZosteriform rashGeneralized rashSkin lesionsVaccine virusVaricellaRashZosterVaccineesWild-type virus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply